| PC | peritoneal carcinomatosis |
| EMT | epithelial-to-mesenchymal transition |
| MET | mesenchymal-to-epithelial transition |
| pEMT | partial epithelial-to-mesenchymal transition |
| IL-6 | interleukin-6 |
| IL-8 | interleukin-8 |
| FGF2 | fibroblast growth factor-2 |
| MCP-1 | monocyte chemoattractant protein-1 (also known as CCL2) |
| IFNγ | interferon gamma |
| IFNα | interferon alpha |
| IL-2 | interleukin-2 |
| IL-10 | interleukin-10 |
| IL-1 | interleukin-1 |
| IL-1R | interleukin-1 receptor |
| TNFR | tumor necrosis factor receptor |
| TRAF2 | tumor necrosis factor receptor-associated factor 2 |
| NF-κB | nuclear factor kappa B |
| NK | natural killer cells |
| PI3K | phosphoinositide 3-kinase |
| PLCβ | phospholipase C beta |
| cAMP | cyclic adenosine monophosphate |
| ROS | reactive oxygen species |
| NET | neutrophil extracellular trap |
| TME | tumor microenvironment |
| AKT | Ak strain transforming pathway |
| CRC | colorectal cancer |
| ERRα | estrogen-related receptor alpha |
| VEGF | vascular endothelial growth factor |
| MMP | matrix metalloproteinase |
| MMP-9 | matrix metalloproteinase-9 |
| ECM | extracellular matrix |
| GM-CSF | granulocyte-macrophage colony-stimulating factor |
| OSM | oncostatin M |
| MDSC | myeloid-derived stem cells |
| TAMs | tissue-associated macrophages |
| ARG1 | arginase-1 |
| NLR | neutrophil to lymphocyte ratio |
| OS | overall survival |
| PFS | progression free survival |
| CEA | carcinoembryonic antigen |
| IL-17 | interleukin-17 |
| TGF-β | transforming growth factor-beta |
| NE | neutrophil elastase |
| HMGB1 | high-mobility group box 1 |
| ELISA | enzyme linked immunosorbent assay |
| RT-qPCR | reverse transcription quantitative polymerase chain reaction |
| CAFs | cancer-associated fibroblasts |
| PD-L1 | programmed death-ligand 1 |
| PD-1 | Programmed Cell Death Protein 1 |
| microRNA | micro-ribonucleic acid |
| HUVEC | human umbilical vein endothelial cells |
| mAB | monoclonal antibody |
| KRAS | Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
| MSS | microsatellite stable |
| MTD | maximum tolerated dose |
| CRPC | castration-resistant prostate cancer |
| NSCLC | non-small cell lung cancer |
| ICIs | immune checkpoint inhibitors |
| MSS CRC | microsatellite stable colorectal cancer |
| TNF-α | Tumor Necrosis Factor alpha |
| COPD | Chronic obstructive pulmonary disease |
| SMI | Small-molecule inhibitor |
| mCRC | mucinous colorectal cancer |
| DNA | deoxyribonucleic acid |
| PFN | profilin-1 |
| GzmB | granzyme B |
| TSC1/2 | Tuberous Sclerosis Complex ½ |
| Rheb | Ras homolog enriched in brain |
| mTORC | mammalian target of rapamycin complex 1 |
| TANs | tumor-associated neutrophils |
| PGE2 | prostaglandin E2 |
| Bv8 | prokineticin 2 |
| IL-1β | interleukin-1 beta |
| HIF-1α | hypoxia inducible factor-1 alpha |
| TLR4 | toll-like receptor-4 |